B. Riley upgraded shares of Eton Pharmaceuticals (NASDAQ:ETON – Free Report) to a strong-buy rating in a research note published on Thursday,Zacks.com reports. ETON has been the topic of several other reports. Craig Hallum increased their target price on Eton Pharmaceuticals from $15.00 to $18.00 and gave the stock a “buy” rating in a research […]

Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) was upgraded by investment analysts at B. Riley to a “strong-buy” rating in a report issued on Thursday,Zacks.com reports. Several other brokerages also recently commented on ETON. HC Wainwright increased their price target on Eton Pharmaceuticals from $15.00 to $17.00 and gave the company a “buy” rating in […]